Quizartinib: <i>FLT3-</i>ITD or not, does it matter?

Authors

Institutions

Publication Details

Journal
Haematologica
Published
2026-06-18
DOI
https://doi.org/10.3324/haematol.2026.301346
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Quizartinib: FLT3-ITD or not, does it matter?

Sabine Kayser
Haematologica
Lung Cancer Treatments and Mutations
article

Quizartinib: FLT3-ITD or not, does it matter?

Sabine Kayser
article en

Abstract

No abstract available for this paper.
Haematologica
German Cancer Research Center (DE), Heidelberg University (DE), German Red Cross (DE), University Hospital Heidelberg (DE)
Openalex Percentile: Top 6%
Lung Cancer Treatments and Mutations
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.